Allspring Global Investments Holdings, LLC Veracyte, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 8,746 shares of VCYT stock, worth $363,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,746
Previous 8,726
0.23%
Holding current value
$363,483
Previous $296,000
16.89%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VCYT
# of Institutions
320Shares Held
80.6MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$324 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$322 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$209 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$176 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$175 Million1.46% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.97B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...